can tirzepatide cause vision loss GLP-1 Drugs Loss? What the Research Says Use of the dual GIP/GLP-1
Description
doi: 10.3389/fpsyt.2018.00250
Title 2 , T
PlexusDx patients access treatment with the support of healthcare providers who monitor progress and adjust approaches based on individual response patterns

For example, in a major phase 3 clinical trial published in 2022, participants with type 2 diabetes lost an average of 15-20% of their body weight over 40 weeks when treated with tirzepatide

A CTA of the aorta ruled out dissection but showed a moderate sized hemopericardium raising concern for a mechanical complication of posterior MI, specifically a free wall rupture (FWR)
Im like, What the hell are you on